A multi-centre, open-label, randomised, two-arm Phase III trial of bevacizumab plus chemotherapy versus chemotherapy alone in patients with platinum-resistant, epithelial ovarian, fallopian tube or primary peritoneal cancer
Trial Number
NCT00976911 (ClinicalTrials.gov Identifier)Contact Person
Status
Completed
Disease Site
Ovarian